---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-012030"
form_type: "8-K"
ticker: "CELC"
cik: "0001603454"
company_name: "Celcuity Inc."
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:21:53.754597+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Celcuity extends Term C Loan draw deadline to June 1, 2024 via Second Amendment with Innovatus

## Summary
- Second Amendment extends Term C Draw Period from April 1, 2024 to June 1, 2024.
- $10M Term C Loan available upon achievement of Term C Milestone and satisfaction of conditions.
- First $15M loan drawn April 2021; $20M additional loan drawn December 2022.
- No other changes to Loan Agreement; up to $75M total borrowing capacity unchanged.
- Representations and warranties reaffirmed; no event of default (except existing defaults).

## SEC filing metadata
- accession: 0001493152-24-012030
- form_type: 8-K
- ticker: CELC
- cik: 0001603454
- company_name: Celcuity Inc.
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603454/000149315224012030/0001493152-24-012030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603454/000149315224012030/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-012030
- JSON: https://secwatch.observer/filing/0001493152-24-012030.json
- Plain text: https://secwatch.observer/filing/0001493152-24-012030.txt

## Key facts
- Debt Financings
  Celcuity Inc. amended credit facility of up to $75.0 million with Innovatus Life Sciences Lending Fund I, L.P..
  - Instrument: credit facility
  - Principal: up to $75.0 million
  - Counterparty: Innovatus Life Sciences Lending Fund I, L.P.
  - Event: amendment
  source text: Amendment, shall be collectively referred to herein as the “Amended Loan Agreement”). As previously disclosed, the Amended Loan Agreement may provide the Company with up to $75.0 million through funding of up to five term loans. Funding of the first $15.0 million term loan occurred on April 8, 2021 in connection with entering into the original Loan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603454/000149315224012030/0001493152-24-012030-index.htm
- Material Agreements
  Celcuity Inc. amended Second Amendment with Innovatus Life Sciences Lending Fund I, L.P. (effective 2024-03-29).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Innovatus Life Sciences Lending Fund I, L.P.
  - Effective: 2024-03-29
  source text: On March 29, 2024, Celcuity Inc. (the “Company”) entered into a Second Amendment (the “Second Amendment”) to its existing Loan and Security Agreement (the “Loan Agreement”), dated April 8, 2021, between the Company and Innovatus Life Sciences Lending Fund I, L.P., a Delaware limited partnership (“Innovatus")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603454/000149315224012030/0001493152-24-012030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.